Microcirculatory changes during open label magnesium sulphate infusion in patients with severe sepsis and septic shock by Andrius Pranskunas et al.
RESEARCH ARTICLE Open Access
Microcirculatory changes during open label
magnesium sulphate infusion in patients
with severe sepsis and septic shock
Andrius Pranskunas1†, Namkje AR Vellinga2,3†, Vidas Pilvinis1, Matty Koopmans2 and E Christiaan Boerma2,3*
Abstract
Background: Microcirculatory alterations play a pivotal role in sepsis and persist despite correction of systemic
hemodynamic parameters. Therefore it seems tempting to test specific pro-microcirculatory strategies, including
vasodilators, to attenuate impaired organ perfusion. As opposed to nitric oxide donors, magnesium has both
endothelium-dependent and non-endothelium-dependent vasodilatory pathways.
Methods: In a single-center open label study we evaluated the effects of magnesium sulphate (MgS) infusion on
the sublingual microcirculation perfusion in fluid resuscitated patients with severe sepsis and septic shock within
the first 48 hours after ICU admission. Directly prior to and after 1 hour of magnesium sulphate (MgS) infusion
(2 gram) systemic hemodynamic variables, sublingual SDF images and standard laboratory tests, were obtained.
Results: Fourteen patients (12 septic shock, 2 severe sepsis) with a median APACHE II score of 20 were enrolled.
No significant difference of the systemic hemodynamic variables was found between baseline and after MgS
infusion. We did not observe any significant difference pre and post MgS infusion in the primary endpoint
microvascular flow index (MFI) of small vessels: 2.25(1.98-2.69) vs. 2.33(1.96-2.62), p = 0.65. Other variables of
microcirculatory perfusion were also unaltered. In the overall unchanged microvascular perfusion there was a non-
significant trend to an inverse linear relationship between the changes of MFI and its baseline value (y = -0.7260 ×
+ 1.629, r2 = 0.270, p = 0.057). The correlation between baseline Mg concentrations and the change in MFI pre-
and post MgS infusion was non-significant (rs = -0.165, p = 0.67).
Conclusions: In the setting of severe sepsis and septic shock sublingual microcirculatory alterations were observed
despite fulfillment of sepsis resuscitation guidelines. After infusion of a limited and fixed dose of MgS,
microcirculatory perfusion did not improve over time.
Trial registration: ClinicalTrials.gov NTC01332734.
Background
Microcirculatory dysfunction in sepsis is crucial in the
pathogenesis of organ dysfunction and consists of a cas-
cade of mechanisms, which involves many cells, such as
endothelial cells, smooth muscle cells, red blood cells
and leukocytes [1]. New microcirculatory imaging tech-
niques, such as orthogonal polarization spectral (OPS)
imaging [2] and its technical successor sidestream dark
field (SDF) imaging [3], have allowed direct observation
of the microcirculation at the bedside. De Backer et al.
[4] were the first to report that the observed microcircu-
latory alterations in sepsis were associated with morbid-
ity and mortality, irrespective of correction of global
hemodynamic variables [5].
Therefore, other strategies that aim to attenuate
microcirculatory dysfunction directly at the level of the
microcirculation, have been tested. According to
Poiseuille’s Law, blood flow through a vessel is directly
proportional to the driving pressure along the vessel and
its radius to the fourth power, and inversely propor-
tional to the length of the vessel and the dynamic blood
viscosity. Theoretically, vasodilators should be able to
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increase blood flow via a change in vessel diameter at
the entrance of the microcirculation and recruit micro-
circulatory perfusion in volume resuscitated patients [6].
Stimulation of endothelium-dependent vasodilation by
topical application of acetylcholine was effective in the
recruitment of shut-down capillaries in septic patients,
thus challenging the concept of vasoplegia [7]. It sug-
gested that endothelial vasodilatory response is intact in
sepsis and microvascular thrombosis is not the predomi-
nant factor in the observed decrease in microcirculatory
blood flow. Thus, an ideal agent to recruit the microcir-
culation in sepsis should have endothelium modulator
and vasodilator characteristics, such as a nitric oxide
(NO) donor [8,9]. However, a recent randomized clinical
trial could not confirm the previous observation, that
nitroglycerin improved microvascular perfusion in an
open label setting [10].
Studies with magnesium (Mg) and magnesium sul-
phate (MgS) have shown a peripheral (predominantly
arteriolar) vasodilator effect with preserved cardiac func-
tion, within a large safety margin [11-13], not only indir-
ectly by an endothelium-dependent release of NO
[14,15] but also directly via its ability to induce endothe-
lium-independent vasodilation by a direct action on vas-
cular smooth muscle as a calcium competitor. In
addition to vasodilatory effects, infusion of MgS is also
associated with other potential pro-microcirculatory
effects, such as an increase in red blood cell deformabil-
ity, reduction of platelet aggregation, anti-inflammatory
effects and maintenance of endothelial integrity [16-19].
However, up to date the effect of MgS infusion on
microvascular perfusion in septic patients, is unknown.
Our study aims to test the hypothesis that MgS infusion
may improve sublingual microcirculatory perfusion in
patients with severe sepsis and septic shock.
Methods
Setting
The study was performed during an 8-months period
in 2010 in a closed-format 15-bed mixed ICU in a uni-
versity hospital. It was designed as a prospective, sin-
gle-centre, open-label trial. Patients were included with
less than 48 hrs duration of severe sepsis or septic
shock as defined by the International Sepsis Definition
Conference [20]. Exclusion criteria were pregnancy,
oral bleeding, age < 18 years, liver cirrhosis, acute
arrhythmias, advanced malignancy or a mean arterial
pressure (MAP) < 65 mmHg refractory to vasopressors.
The study was carried out in compliance with the Hel-
sinki Declaration and approved by the local ethics
committee (Kauno Regioninis Biomedicininiu Tyrimu
Etikos Komitetas, 201003.03 nr BE-2-6) and informed
consent was obtained from each patient, according to
applicable laws.
Protocol and data collection
All patients were equipped with an arterial line and cen-
tral venous catheter or a pulmonary artery catheter
(TD-I, B.Braun Medical, Bethlehem, USA). Prior to the
start of MgS infusion, all patients followed a strict pro-
tocol to optimize systemic hemodynamic parameters in
accordance with international guidelines for manage-
ment of sepsis [21]. Patients were resuscitated such that
mean MAP was ≥ 65 mm Hg, central venous pressure
no less than 8 mm Hg and mixed venous saturation
(SvO2) ≥ 65% or central venous saturation (S(c)vO2) ≥
70%. Red blood cell transfusion trigger was a haemato-
crit < 25%. Sedation and analgesia was provided with
midazolam and fentanyl.
After achieving these therapeutic endpoints, MgS infu-
sion was started at a rate of 2 g over 1 hour. For safety
reasons, a sustained MAP < 65 mm Hg during infusion
despite protocolized treatment constituted a reason to
stop MgS infusion permanently.
The following data were recorded at baseline: general
characteristics, Acute Physiology and Chronic Health
Evaluation II (APACHE II) score, calculated over the
first 24 hrs following ICU admission and Sequential
Organ Failure Assessment (SOFA) score, calculated at
study time. Directly prior to and within 10 minutes after
cessation of MgS infusion systemic hemodynamic vari-
ables, sublingual SDF images and standard laboratory
tests, including arterial and central/mixed venous blood
gasses were obtained. ICU and hospital length of stay
(LOS) and mortality were registered afterwards.
Videomicroscopic measurements and analysis
Images of the sublingual microcirculation were obtained
with SDF videomicroscopy (Microscan®, Microvision
Medical, Amsterdam, the Netherlands) [3]. After gentle
removal of saliva and other secretions by an isotonic sal-
ine-drenched gauze, the device was applied to sublingual
region, avoiding pressure artifacts by establishing a
threshold-image. Sequences of 20 seconds from at least
three areas were recorded on hard disk using a personal
computer and AVA v3.0 software (Microvision medical,
Amsterdam, The Netherlands). Video clips were blindly
analyzed offline by two investigators in random order to
prevent coupling. Assessment of microcirculatory para-
meters of convective oxygen transport (microvascular
flow index (MFI) and proportion of perfused vessels
(PPV)), and diffusion distance (perfused vessel density
(PVD) and total vessel density (TVD)) was done accord-
ing to published recommendations [22]. Vessels were
separated into large (mostly venules) and small (mostly
capillaries) using a diameter cutoff value of 20 μm. The
final MFI score is the average values of 3 × 4 quadrants.
Heterogeneity index was calculated as the difference
between the highest and lowest MFI, divided by the
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mean MFI of all sublingual sites at a single time point
[23].
Statistical analysis
Primary outcome is sublingual MFI of small vessels. We
anticipated a standard deviation in difference of
response of 0.5. We calculated a sample size of 14
patients to detect a absolute difference of 0.4 in a two-
sided test with 0.05 type I error and a 80% probability.
The Statistical Package for Social Sciences (SPSS 15.1
for Windows, Chicago, USA) was used for statistical
analysis. With respect to small numbers data are pre-
sented as the median (25th-75th percentiles) and ana-
lyzed with non-parametric Wilcoxon signed rank test




Fourteen patients (12 with septic shock and 2 with
severe sepsis) with a median APACHE II score of 20
were enrolled, within 24 hours after the initial sepsis
resuscitation. Baseline characteristics are summarized in
Table 1. Hospital mortality was 57% and all patients sur-
vived the first day after MgS infusion. A source of infec-
tion was confirmed in all cases. No predefined sustained
hypotension during MgS infusion was reported.
Hemodynamic data
No significant difference in systemic hemodynamic
variables was found between baseline and after MgS
infusion (Table 2). Furthermore, we did not observe any
significant difference pre and post MgS infusion in the
primary endpoint MFI of small vessels: 2.25(1.98-2.69)
vs. 2.33(1.96-2.62), p = 0.65 (Figure 1). Other variables
of microcirculatory perfusion were also unaltered
(Table 3). In the overall unchanged microvascular perfu-
sion there was a non-significant trend to an inverse linear
relationship between the changes of MFI of small vessels
and baseline values of MFI of small vessels (y = -0.7260 ×
+ 1.629, r2 = 0.270, p = 0.057, Figure 2). We also observed
non-significant trends of inverse linear relationship
between the changes in TVD of small vessels and baseline
values. (Figure 3). Baseline value for total Mg was 0.9
(0.75-0.99); normal value for total magnesium is 0.9-1.2
mEq/l. The correlation between baseline Mg concentra-
tions and the change in MFI pre- and post MgS infusion
was non-significant (rs = -0.165, p = 0.67).
Discussion
To our knowledge, this is the first study in which the
effect of Mg on the human microcirculation is visualized
directly in patients with sepsis. The main finding of our
study is that MgS infusion had no effect on both sublin-
gual microvascular perfusion and systemic hemody-
namic variables in this setting. This is not in line with
previous observations, that evaluated the effect of MgS
on microcirculatory perfusion under non-septic condi-
tions. In vivo plethysmography of the forearm in healthy
volunteers during intra-arterial MgS infusion revealed a
Table 1 Baseline characteristics
Age, yrs 62(42-74)
Gender, male/female, n 8/6




Skin and soft tissues 2
Hospital mortality, n(%) 8(57)
ICU length of stay, days 5(3-11)
APACHE II score 20(14-26)
SOFA score 8(5-10)
Vasopressors, n 12
Dopamine, n; μg/kg per min 5; 8.0(5.5-9.0)
Norepinephrine, n; μg/kg per min 9; 0.12(0.06-0.23)
Mechanical ventilation, n 13
PEEP, cm H2O 5(5-5)
FIO2, % 55(50-55)
Total magnesium, mEq/l 0.90(0.75-0.99)
Potassium, mEq/l 4.1(3.7-4.4)
Hematocrit, % 30(27-36)
APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sepsis-
related Organ Failure Assessment; PEEP, positive end-expiratory pressure. Data
are presented as median (25th-75th percentiles). Normal value for total
magnesium is 0.9-1.2 mEq/l.
Table 2 Systemic hemodynamic data
Baseline MgS p
Value
Heart rate, beats/min 98(85-113) 94(83-115) 0.98
Mean arterial pressure, mm Hg 71(70-75) 70(67-73) 0.22
Central venous pressure, mm Hg 12(12-13) 12(11-13) 0.29
Vasopressors, n 12 12
Dopamine, n; μg/kg per
min












9; 73(71-74) 9; 72(72-73) 0.39
Mixed venous oxygen saturation,
n; %
5; 68(65-72) 5; 69(65-71) 0.72
Cardiac output, n; L/min 5; 5.4(4.6-6.8) 5; 5.5(4.8-6.4) 0.59






MgS, magnesium sulphate. Data are presented as median (25th-75th
percentiles).
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marked increased in blood flow. In an animal model
with direct in-vivo microscopy of the microcirculation,
both topical and intravenous application of Mg-com-
pounds demonstrated vasodilatory effects in mesenteric
arterioles (10-20 μm) and venules (15-30 μm), that
could not be blocked by cyclo-oxygenase inhibition [24].
This effect was also observed during catecholamine-
induced vasoconstriction [25].
The discrepancy between these results and our obser-
vations may in part be explained by a difference in tech-
nique. Plethysmography incorporates artiolar, capillary
and venular blood flow. In sepsis however, a heteroge-
neous distribution of altered capillary blood flow is
observed, often despite maintenance of both artial and
venular blood flow. In contrast to plethysmography,
SDF enables discrimination between these different vas-
cular compartments. Furthermore, sublingual SDF ima-
ging may not necessarily reflect microvascular perfusion
abnormalities in vascular beds of other organs [26].
Whether the sensitivity of software-supported analysis
of TVD of vessels equals to direct diameter measure-
ments of vessels during in-vivo microscopy remains to
be established and is very sensitive to adequate focus.
The classical response to overcome microvascluar per-
fusion abnormalities in shock has always been to raise
arterial pressure by means of vasopressors, in order to
increase the net perfusion pressure over the microvascu-
lar compartment. However, according to physiological
theory, the drop in perfusion pressure prior to the
microcirculation is equal to the increase in artiolar resis-
tance, thus reducing its pro-microcirculatory flow effect
[27]. Recent studies indeed failed to demonstrate a pro-
microcirculatory effect after a stepwise increase of blood
pressure with norepinephrine [28,29]. Although the
alternative concept of vasodilation to recruit microcircu-
latory perfusion in sepsis is tempting [30], up till now
no clinically available vasodilators with pro-microcircu-
latory characteristics have been discovered. Despite
promising results in a small group of patients [9], nitro-
glycerin showed no effect on microcirculatory perfusion
in a randomized placebo controlled trial in patients with
severe sepsis and septic shock [10]. Both the latter study
and the presented trial have in common that a vasodila-
tor was infused on top of a strict resuscitation protocol,
making hypovolemia unlikely. Even under well-descript
vasodilatory effects of epidural anesthesia, hypervolemic
hemodilution completely blunted microcirculatory
changes in flow and capillary density of the vaginal
mucosa [31]. The absence of effect of a vasodilator in
this setting, both on macro- and microcirculatory vari-
ables, may be in line with maximal pre-capillary smooth
muscle relaxation prior to the start of the intervention.
This is particularly of note since, unlike nitroglycerin,
MgS has an additional non-endothelium dependent
pathway to exert its vasodilatory capacities, by a direct
action on vascular smooth muscle relaxation as a cal-
cium antagonist [15].
Our study has a number of limitations. Due to the
open label setting and relatively small numbers a modest
effect of MgS infusion on microcirculatory perfusion
Figure 1 Change of microvascular flow index pre- and post
magnesium sulphate infusion
Table 3 Microcirculation perfusion data
Baseline MgS p Value
Microvascular flow index of small vessels 2.25(1.98-2.69) 2.33(1.96-2.62) 0.65
Microvascular flow index of large vessels 3.00(3.00-3.00) 3.00(3.00-3.00) 0.79
Proportion of perfused small vessels, % 81.5(78.8-89.3) 85.0(79.3-86.3) 0.64
Total vessel density of small vessels, mm/mm2 26.9(23.2-30.1) 27.8(24.4-29.5) 0.86
Total vessel density of others vessels, mm/mm2 7.4(6.2-8.9) 6.6(5.8-8.0) 0.26
Perfused vessel density of small vessels, n/mm 13.4(11.8-15.8) 13.6(11.5-15.1) 0.59
Perfused vessel density of other vessels, n/mm 4.2(3.7-4.7) 4.0(3.3-5.0) 0.97
Heterogeneity index 0.30(0.08-0.54) 0.42(0.26-0.50) 0.51
MgS, magnesium sulphate. Data are presented as median (25th-75th percentiles).
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may have remained unnoticed. Baseline MFI was
decreased despite resuscitation, but only to a moderate
extend. Although this may have blunted a potential
pro-microcirculatory effect of MgS, we only observed a
non-significant and weak correlation between baseline
MFI and change in MFI in response to therapy. It
must be stated however, that post-hoc linear regression
analysis itself is limited by the narrow range of vari-
ables. We deliberately chose this strategy, since we
consider it key not to replace therapeutic macro-hemo-
dynamic strategies by micro-hemodynamic strategies,
but to add micro-hemodynamic strategies in case of
remaining microcirculatory abnormalities, despite opti-
mal macro-hemodynamic resuscitation. In our study
we used a continuous fixed dose of MgS without bolus
due to safety reason, since some data show, that higher
doses of MgS may inhibit catecholamine release
[32,33]. Endothelium-independent vasodilation is asso-
ciated with venous Mg concentrations, but the
endothelium-mediated vasodilatory pathway of Mg
appears to be activated, irrespective of its plasma levels
[14]. In the present study there was no correlation
between baseline Mg concentrations and the change in
MFI pre- and post MgS infusion. We failed to report
plasma Mg concentrations after infusion. The observa-
tion period after the intervention was without delay.
This may have been too short to allow microcircula-
tory alterations to respond to the intervention. On the
other hand, longer observation periods in an open
label setting carry a considerable risk of improvement
over time, irrespective of the intervention itself. There-
fore, we cannot rule out that a higher dose, a different
loading regiment, suppletion to a pre-defined plasma
Mg concentrations or a longer post-intervention obser-
vation period may have revealed more potential of
MgS infusion for the improvement of microcirculatory
perfusion in sepsis.
Conclusion
In the setting of severe sepsis and septic shock sublin-
gual microcirculatory alterations were observed despite
fulfillment of sepsis resuscitation guidelines. After infu-
sion of a limited and fixed dose of MgS, microcircula-
tory perfusion did not improve over time.
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